NatureWise Biotech & Medicals Corporation (4732.TWO)
- Previous Close
20.30 - Open
20.25 - Bid 18.90 x --
- Ask 19.75 x --
- Day's Range
19.00 - 20.25 - 52 Week Range
17.40 - 27.50 - Volume
72,496 - Avg. Volume
51,350 - Market Cap (intraday)
1.11B - Beta (5Y Monthly) --
- PE Ratio (TTM)
987.50 - EPS (TTM)
0.02 - Earnings Date --
- Forward Dividend & Yield 0.18 (0.89%)
- Ex-Dividend Date Aug 27, 2024
- 1y Target Est
--
NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; PPL Taiwan green propolis; and NBM-BMX, an oral softgel capsule to treat cancer. The company was founded in 2000 and is based in Taipei, Taiwan.
www.naturewise.com.twRecent News: 4732.TWO
View MorePerformance Overview: 4732.TWO
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4732.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4732.TWO
View MoreValuation Measures
Market Cap
1.11B
Enterprise Value
501.72M
Trailing P/E
990.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.96
Price/Book (mrq)
1.50
Enterprise Value/Revenue
2.24
Enterprise Value/EBITDA
67.28
Financial Highlights
Profitability and Income Statement
Profit Margin
0.40%
Return on Assets (ttm)
-0.98%
Return on Equity (ttm)
-0.50%
Revenue (ttm)
224.32M
Net Income Avi to Common (ttm)
897k
Diluted EPS (ttm)
0.02
Balance Sheet and Cash Flow
Total Cash (mrq)
614.73M
Total Debt/Equity (mrq)
0.43%
Levered Free Cash Flow (ttm)
-3.58M